Treatment of Type 1 Diabetes with Anti-CD3 Monoclonal Antibody

By Glandt Mariela   Hagopian William   Herold Kevan C.  

Reviews in Endocrine and Metabolic Disorders, Vol. 4, Iss. 4, 2003-12 ,pp. : 361-368

Springer Publishing Company

Access to resources Recommend Favorite

Efalizumab, a Human Monoclonal Anti-CD11a Antibody, in the Treatment of Moderate to Severe Crohn’s Disease: An Open-Label Pilot Study

By James Dustin   Seo Da   Chen Jiajing   Vemulapalli Caroline   Stone Christian  

Digestive Diseases and Sciences, Vol. 56, Iss. 6, 2011-06 ,pp. : 1806-1810

Springer Publishing Company

Access to resources Recommend Favorite

Infective endocarditis complicating rituximab (anti-CD20 monoclonal antibody) treatment in an SLE patient with a past history of Libman–Sacks endocarditis: a case for antibiotic prophylaxis?

By Armstrong David   Wright Stephen   McVeigh Claire   Finch Michael  

Clinical Rheumatology, Vol. 25, Iss. 4, 2006-07 ,pp. : 583-584

Springer Publishing Company

Access to resources Recommend Favorite

Biopsy-verified response of severe lupus nephritis to treatment with rituximab (anti-CD20 monoclonal antibody) plus cyclophosphamide after biopsy-documented failure to respond to cyclophosphamide alone

By Vollenhoven RF van   Gunnarsson I   Welin-Henriksson E   Sundelin B   Österborg A   Jacobson SH   Klareskog L  

Scandinavian Journal of Rheumatology, Vol. 33, Iss. 6, 2004-11 ,pp. : 423-427

Informa Healthcare

Access to resources Recommend Favorite

Glycoxidised LDL isolated from subjects with impaired glucose tolerance increases CD36 and peroxisome proliferator–activator receptor γ gene expression in macrophages

By Graessler J.   Pietzsch J.   Westendorf T.   Julius U.   Bornstein S.   Kopprasch S.  

Diabetologia, Vol. 50, Iss. 5, 2007-05 ,pp. : 1080-1088

Springer Publishing Company

Access to resources Recommend Favorite